Benzinga | Nov 10, 2020 04:01PM EST

Soleno Therapeutics Q3 EPS $(0.11) Down From $0.03 YoY

Soleno Therapeutics (NASDAQ:SLNO) reported quarterly losses of $(0.11) per share. This is a 466.67 percent decrease over earnings of $0.03 per share from the same period last year.